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Abstract
Objective: Interleukin-1b (IL-1b) is a pro-inflammatory cytokine that plays a key role in the pathogenesis of osteoarthritis
(OA). Growth factors (GFs) capable of antagonizing the catabolic actions of cytokines may have therapeutic potential in the
treatment of OA. Herein, we investigated the potential synergistic effects of insulin-like growth factor (IGF-1) and platelet-
derived growth factor (PDGF-bb) on different mechanisms participating in IL-1b-induced activation of nuclear transcription
factor-kB (NF-kB) and apoptosis in chondrocytes.
Methods: Primary chondrocytes were treated with IL-1b to induce dedifferentiation and co-treated with either IGF-1 or/and
PDGF-bb and evaluated by immunoblotting and electron microscopy.
Results: Pretreatment of chondrocytes with IGF-1 or/and PDGF-bb suppressed IL-1b-induced NF-kB activation via inhibition
of IkB-a kinase. Inhibition of IkB-a kinase by GFs led to the suppression of IkB-a phosphorylation and degradation, p65
nuclear translocation and NF-kB-regulated gene products involved in inflammation and cartilage degradation (COX-2,
MMPs) and apoptosis (caspase-3). GFs or BMS-345541 (specific inhibitor of the IKK) reversed the IL-1b-induced down-
regulation of collagen type II, cartilage specific proteoglycans, b1-integrin, Shc, activated MAPKinase, Sox-9 and up-
regulation of active caspase-3. Furthermore, the inhibitory effects of IGF-1 or/and PDGF-bb on IL-1b-induced NF-kB
activation were sensitive to inhibitors of Src (PP1), PI-3K (wortmannin) and Akt (SH-5), suggesting that the pathway
consisting of non-receptor tyrosine kinase (Src), phosphatidylinositol 3-kinase and protein kinase B must be involved in IL-1b
signaling.
Conclusion: The results presented suggest that IGF-1 and PDGF-bb are potent inhibitors of IL-1b-mediated activation of NF-
kB and apoptosis in chondrocytes, may be mediated in part through suppression of Src/PI-3K/AKT pathway, which may
contribute to their anti-inflammatory effects.
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Introduction
Osteoarthritis is a metabolically active, dynamic process that
involves all joint tissues (cartilage, bone, synovium/capsule,
ligaments and muscle). It is the most common clinical syndrome
of joint pain accompanied by varying degrees of functional
limitation and reduced quality of life [1]. Key pathological changes
in OA include localised loss of articular cartilage and remodelling
of adjacent bone with new bone formation (osteophyte) at the joint
margins. These changes lead to episodes of chronic joint pain,
limitation of movement and ultimately disability [2,3]. At the
molecular level OA is characterized by an imbalance between
cartilage extracellular matrix (ECM) anabolism and catabolism
which is mediated mainly by pro-inflammatory cytokines such as
interleukin-1b (IL-1b) and tumor necrosis factor-a (TNF-a) [4].
IL-1b is one of the main cytokines that has been implicated in the
pathogenesis of degenerative joint diseases such as OA and
rheumatoid arthritis (RA) [5,6]. This cytokine induces the releases
of matrix degenerative enzymes (matrix metalloproteinases,
MMPs) and inhibits the synthesis of extracellular matrix proteins
in chondrocytes [7]. IL-1b also induces cell apoptosis, which leads
to further degenerative changes in cartilage [8].
The remodeling of cartilage-specific matrix components is a
pre-requisite for chondrocyte differentiation and survival [9]. b1-
integrins are transmembrane signal transduction receptors in the
chondrocyte membrane mediating essential cell–matrix interac-
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chondrocytes and extracellular matrix macromolecules [10].
Disruption of cell-matrix interactions by inhibition of the
MAPKinase pathway has been reported to lead to caspase-3
cleavage and chondrocyte apoptosis [11,12]. Therefore, it is of
great importance to elucidate the molecular and cellular
mechanisms involved in cartilage inflammation and chondrocyte
responses to pro-inflammatory cytokines in order to develop new
treatments to protect cartilage in degenerative joint diseases.
Many pro-inflammatory effects of IL-1b and TNF-a in arthritis
are regulated by activated ubiquitous central transcription factor
nuclear factor-kB (NF-kB). In chondrocytes NF-kB is a key
regulator of cyclooxygenase 2 (COX-2) and MMP expression
[13,14,15,16]. NF-kB regulates the expression of a large number
of genes in response to infection, inflammation, adhesion, cell cycle
and survival. In the absence of inflammatory signals NF-kB exists
as an inactive cytoplasmic heterotrimer-complex by association
with an inhibiting IkBa subunit. In response to phosphorylation,
IkBa dissociates from the complex and the p65 and p50 subunits
freely translocate to the nucleus and bind to NF-kB recognition
sites in the promoter regions of various NF-kB regulated genes
[17]. NF-kB appears to be a common target of multiple
converging catabolic signalling pathways mediated by pro-
inflammatory cytokines.
Pro-anabolic growth factors influence important cellular
processes including differentiation, growth, survival and antago-
nize the effects of inflammatory mediators [18]. IGF-1 is one of the
main anabolic growth factors in cartilage and plays an essential
role in cartilage homeostasis and balancing proteoglycan synthesis.
It stimulates proteoglycan and collagen type II production in
chondrocytes [12,19]. We have previously shown that IGF-1 plays
an important role in chondrocyte differentiation; IGF-1 stimula-
tion of the IGF-1 receptor activates key signaling proteins of the
MAPK pathway [20]. The presence of PDGF-bb in cartilage
defects exerts chemotactic and mitogenic effects on cells in the
surrounding cartilage and could stimulate the infiltration of
mesenchymal stem cells [4]. PDGF-bb also has a direct effect on
chondrocyte proliferation, differentiation and cartilage proteogly-
can production [21].
Although growth factors can prevent apoptosis by eliciting anti-
apoptotic signals in chondrocytes [22] the mechanisms involved
have not been elucidated at the molecular level. Despite the
importance of PDGF-bb and IGF-1 as factors potentially capable
of stimulating cartilage repair, very little is known about their
anabolic effects on chondrocytes. Therefore the aim of this study
was to investigate the hypothesis that PDGF-bb and IGF-1 can
promote proliferation, differentiation and inhibit chondrocyte
apoptosis in a synergistic manner by modulating the NF-kB
pathway and associated signalling pathways and expression of
downstream inflammatory molecules.
Materials and Methods
Antibodies
Antibodies against collagen type II (AB746), cartilage-specific
proteoglycan (MAB 2015) and b1-integrin (MAB1977) and
alkaline phosphatase linked sheep anti-mouse and sheep anti-
rabbit secondary antibodies for immunoblotting were purchased
from Millipore (Schwalbach, Germany). Antibodies to active
caspase-3 (AF835), MMP-9 (MAB 911) and MMP-13 (MAB 511)
were from R&D Systems, Inc., (Heidelberg, Germany). SOX-9
antibody was purchased from Acris Antibodies GmbH (Hidden-
hausen, Germany). Cyclo-oxygenase-2 (160-112) antibody was
obtained from Cayman Chemical (Ann Arbor, MI, USA).
Monoclonal anti-b-actin was purchased from Sigma-Aldrich
(Munich, Germany). Monoclonal anti-phospho-p42/p44 Erk1/2
and polyclonal anti-Shc were purchased from BD (BD Biosciences,
Belgium). Antibodies against p65, pan-IkBa, phosphatidylinositol
3-kinase (PI-3K) p85 and c-Src were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Antibodies against phospho-
specific IkBa (Ser 32/36) and anti-phospho-specific p65 (Ser536)
were obtained from Cell Technology (Beverly, MA). Anti-IkBa
kinase (IKK)-a and anti-IKK-b antibodies were obtained from
Imgenex (Germany).
Growth media and biochemicals
Growth medium (Ham’s F-12/Dulbecco’s modified Eagle’s
medium (50/50) containing 10% fetal calf serum (FCS), 25 mg/ml
ascorbic acid, 50 IU/ml streptomycin, 50 IU/ml penicillin,
2.5 mg/ml amphotericin B, essential amino acids and L-glutamine)
was obtained from Seromed (Munich, Germany). BMS-345541,
Pronase, collagenase and Trypsin/EDTA (EC 3.4.21.4) were
purchased from Sigma (Munich, Germany). Epon was obtained
from Plano (Marburg, Germany). IGF-1, PDGF-bb and IL-1b
were purchased from Acris (Hiddenhausen, Germany). Wortman-
nin and PP1 were purchased from Biomol (Plymouth Meeting,
PA, USA). SH-5 was from Calbiochem (La Jolla, CA, USA).
Chondrocyte isolation and culture
Cartilage tissue samples from healthy femoral head articular
cartilage obtained during joint replacement surgery for femoral
neck fractures were used to isolate primary canine chondrocytes as
previously described in detail [23]. Samples were obtained during
total hip replacement surgery at Clinic of Small Animals with fully-
informed owner consent and ethical project approval from the
ethical review committee of the Ludwig-Maximilian-University
Munich, Germany. However, for our in vitro study on such
materials no approval was necessary because no direct contact
with live animals was involved at all.
Samples were obtained during total hip replacement surgery
with fully-informed owner consent and ethical project approval
from the ethical review committee of the Ludwig-Maximilian-
University Munich, Germany. In total, the experiments were
performed three times and samples from three different donors
were used. Donor ages ranged from 5 to 7 years. Briefly, for
chondrocyte isolation the cartilage sample was sliced into 1–2 mm
thick slices and incubated first with pronase (2%/Hams-F12)
(Roche Diagnostics), followed by collagenase incubation (0.2%/
Ham’s-F12) in a shaking water bath at 37uC. The digested sample
was centrifuged at 1000 g/5 min and cells plated at 1610
6 cells
per T75 flask at 37uC/5%CO2. The first medium change was
performed after 24 h, and following medium changes three times
per week. Chondrocytes were split at ca. 70% confluency and
passaged twice.
Experimental design
The experiments performed in this study were performed on
primary chondrocytes and specifically designed to mimic cellular
events that occur in the clinical condition of OA. To stimulate
chondrocyte dedifferentiation processes in monolayer cultures, we
adopted a model, which stimulates cells with the pro-inflammatory
cytokine IL-1b (10 ng/ml). During monolayer expansion chon-
drocytes were cultured in whole cell culture medium containing
10% FCS. Chondrocytes were washed three times with serum-
starved medium (containing only 0.5% FCS) and further
incubated for 30 min with the same medium before initiating
treatment with IL-1b. Serum-starved chondrocytes were stimulat-
ed with IL-1b alone or with IGF-1 (10 ng/ml), PDGF-bb (10 ng/
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factors (each 5 ng/ml) or pre-stimulated with IGF-1 (10 ng/ml),
PDGF-bb (10 ng/ml), BMS (5 mM) or a combination of both
growth factors (each 5 ng/ml) for 12 h before treating with IL-1b
for an additional 24 or 48 h. The growth factor concentrations
used in this study are the same as those in previous studies from
our own laboratory and were calculated through dose dependent
experiments on human articular chondrocytes. In a second
approach, monolayer cultured chondrocytes, treated as above,
were transferred to high-density cultures and cultured under
identical conditions with serum starved-medium to examine the
effects of IGF-1 and/or PDGF-bb on chondrocyte differentiation
potential in a three dimensional environment. Three dimensional
high-density culture was performed as previously described [24].
Briefly, 1610
6 cells were pipetted onto a nitrocellulose filter resting
on a steel net bridge. Cell culture medium reached the filter
medium interface and cells were nurtured through diffusion. After
one day in culture cells aggregated and formed a pellet on the
filter.
For investigation of NF-kB translocation and IkBa phosphor-
ylation chondrocyte cultures were treated either with 10 ng/ml
IL-1b or co-treated with 10 ng/ml IL-1b and IGF-1 (10 ng/ml) or
PDGF-bb (10 ng/ml) or the combination of both growth factors
(each 5 ng/ml) for 0, 5, 10, 20, 40 and 60 min and nuclear and
cytoplasmic extracts were prepared. These experiments were
performed in triplicate and the results are provided as mean values
from three independent experiments.
Isolation of chondrocyte cytoplasmic and nuclear
extracts
Isolation of cytoplasmic and nuclear extracts was performed as
previously described in detail [25]. Briefly, chondrocytes were
trypsinized and washed twice in 1 ml ice cold PBS. The cell pellet
was re-suspended in 400 ml hypotonic lysis buffer containing
protease inhibitors and incubated on ice for 15 min. 12.5 mlo f
10% NP-40 were added and the cell suspension vigorously mixed
for 15 seconds. The extracts were centrifuged for 1.5 min. The
supernatants (cytoplasmic extracts) were frozen at 270uC.
Approximately 25 ml of ice cold nuclear extraction buffer was
added to the pellets and incubated for 30 min with intermittent
mixing. Extracts were centrifuged and the supernatant (nuclear
extracts) transferred to pre-chilled tubes for storage at 270uC.
Western blot analysis
For western blot analysis, monolayer cultures were treated on
ice for 30 min with lysis buffer (50 mM Tris/HCl, pH 7.2/
150 mM NaCl/(v/v) Triton X-100/1 mM sodium orthovana-
date/50 mM sodium pyrophosphate/100 mM sodium fuoride/
4 mg/ml pepstatin A/1 mM PMSF) as previously described [11].
After centrifugation at 9,000 g for 30 min, the supernatant was
stored at 280uC until further use. Total protein content of each
lysate was determined with the bicinchoninic acid system using
BSA as standard (Uptima, Monlucon, France). Samples were
reduced with 2-mercaptoethanol on a heat block for 10 min at
90uC and total protein concentrations were adjusted. Proteins
were separated using SDS-PAGE under reducing conditions
using 5%, 7.5%, 10% and 12% polyacrylamide gels and blotted
onto nitrocellulose membranes using a transblot electrophoresis
apparatus (Bio-Rad, Germany) for 60 min at 120 volts. Further,
membranes were transferred to blocking buffer (skimmed milk
powder in 1% PBS and Tween 20) for 2 h, and then incubated
with primary antibody overnight at 4uC. Following washing
3610 min with blocking buffer, membranes were incubated with
secondary antibody for 90 min. After more washing in 0.1 M
Tris buffer (0.05 M MgCl2/0.1 M NaCl), specific antigen-
antibody complexes were detected by nitroblue tetrazolium and
5-bromo-4-chloro-3-indoylphosphate as substrates for alkaline
phosphatase.
Transmission electron microscopy
Cell cultures were fixed in Karnovsky’s fixative for 30 min and
post-fixed in a 1% OsO4 solution. Samples were dehydrated in an
ascending alcohol series before they were embedded in Epon, and
cut on a Reichert Ultracut. 2% uranyl acetate/lead citrate was
used for contrasting these ultrathin sections, as previously
described [12].
Immune complex kinase assay
Immune complex kinase assay was performed as previously
described in detail [23]. Briefly, to test the effect of BMS, IGF-1 or
PDGF-bb on IL-1b-induced IKK activation, immune complex
kinase assays were performed. The IKK complex was immuno-
precipitated from whole chondrocyte lysates with antibodies
against IKK-a and IKK-b and subsequently incubated with
protein A/G-agarose beads (Pierce, Germany). After 2 h incuba-
tion, the beads were washed with lysis buffer and resuspended in a
kinase assay solution containing 50 mM HEPES (pH 7.4), 20 mM
MgCl2, 2 mM dithiothreitol, 10 mM unlabeled ATP and 2 mg
substrate GST-IkBa (amino acid 1–54) and incubated at 30uC for
30 min. This was followed by boiling in SDS-PAGE sample buffer
for 5 min. Proteins were separated using SDS-page under
reducing conditions as described above. Phosphorylation of
GST-IkBa was assessed using a specific antibody against
phospho-specific IkBa (Ser 32/36). To demonstrate the total
amounts of IKK-a and IKK-b in each sample, whole-cell proteins
were separated using SDS-PAGE under reducing conditions as
described above. Detection of IKK-a and IKK-b was performed
by immunoblotting with either anti-IKK-a or anti-IKK-b
antibodies.
Pharmacological inhibition experiments
Chondrocytes (5610
4 cells/petri dish) were grown in growth
medium for 24 h. PI-3K inhibitor (wortmannin), Src inhibitor
(PP1) and Akt inhibitor (SH-5) treatments were carried out in
serum-starved medium. Chondrocytes were pre-treated for 1 h
with serum-starved medium containing wortmannin (20 nM), PP1
(10 mM) or SH-5 (10 mM), treated with IGF-1 (10 ng/ml) or
PDGF-bb (10 ng/ml) or the combination of both growth factors
(each 5 ng/ml) for 4 h, and then exposed to 10 ng/ml IL-1b for
1 h. After these treatments, nuclear extracts were prepared and
examined for NF-kB as described in Materials and Methods.
Statistical analysis
Specific binding of each protein was measured and semi-
quantitatively analysed using the densitometric evaluation software
package Quantity One (Bio-Rad Laboratories Inc., Munich,
Germany). The results are shown as the mean 6 SD of a
representative experiment performed three times. Data shown are
representative of three independent experiments.
Results
To examine the effect of PDGF-bb or/and IGF-1 on the NF-kB
activation pathway, we used IL-1b because the pathway activated
by this cytokine is relatively well understood.
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features and apoptosis in chondrocytes in monolayer
culture and promote redifferentiation of IL-1b-treated
chondrocytes in high-density culture
We designed to investigate whether PDGF-bb or/and IGF-1
modulate degenerative effects of IL-1b in chondrocytes. Primary
chondrocytes were exposed to indicated concentrations of PDGF-
bb or/and IGF-1 before co-treatment with IL-1b as explained in
materials and methods. The effect of PDGF-bb or/and IGF-1 on
IL-1b-induced chondrocytes ultrastructural morphology and
ECM formation was evaluated by electron microscopy. Untreated
chondrocytes exhibited a typical fibroblast-like shape with mostly
large euchromatic nuclei containing nucleoli, a well organized
cytoplasm and tiny cytoplasmic processes after 24 and 48 h of
culture (Fig. 1A: a and b). While treatment of chondrocytes with
IL-1b, the cells altered their appearance, resulted in severe
degenerative features such as swelling of rough endoplasmic
reticulum and mitochondria, formation of vacuoles in cytoplasm
and condensation of heterochromatin (Fig. 1A: c). Longer
exposure (48 h) of chondrocytes to IL-1b led to more severe
inflammation and cellular degeneration, such as formation of
autophagic vacuoles in cytoplasm, lots of tiny cytoplasmic
processes and also changes in flattened features of chondrocytes
to rounded and apoptotic appearances (Fig. 1A: d). Chondrocytes
that were pre-treated with IGF-1 or/and PDGF-bb for 12 h and
then treated with IL-1b for an additional 24 or 48 h did not show
severe ultrastructural and morphological changes (Fig. 1A: e–j). In
the presence of growth factors, mitochondrial swelling, spherical
chondrocytes and heterochromatin condensation disappeared
(Fig. 1A: e–h). Co-treatment of chondrocytes with both growth
factors decreased the characteristic signs of cellular destruction
and organelle degeneration in a time dependent manner
indicating a synergistic effect (Fig. 1A: i–j).
We have previously reported that high-density culture can
promote chondrocyte differentiation since it supports cell-cell
interactions [12,26]. We examined whether PDGF-bb or/and
IGF-1 can modulate IL-1b-induced dedifferentiation of chondro-
cytes in high-density culture. High-density cultures were stimulat-
ed with IL-1b alone or exposed to the indicated concentrations of
growth factors before treatment with IL-1b. The ultrastuctural
morphology of the cells and the formation of ECM macromol-
ecules was evaluated using electron microscopy. Untreated
chondrocytes were viable and exhibited round to oval shapes
with large mostly euchromatic nuclei, mitochondria, rough
endoplasmic reticulum and a well structured ECM (Fig. 1B: a).
IL-1b resulted in degenerative and apoptotic features including
Figure 1. A: a–j: Effects of IGF-1 or/and PDGF-bb on IL-1b-induced apoptosis and cellular degeneration in chondrocytes. Transmission
electron microscopy was performed to study the effects of IGF-1 or/and PDGF-bb on IL-1b-stimulated primary chondrocytes. Untreated control
cultures consist of vital, active cells containing a well-developed rough endoplasmic reticulum, mitochondria and a well-organized cytoplasm after 24
or 48 h in culture (a and b). In contrast, stimulation with IL-1b for 24 h led to degenerative changes including condensation of heterochromatin,
swelling of the rough endoplasmic reticulum and mitochondria (c). Longer exposure (48 h) to IL-1b resulted in more severe degenerative features
including formation of apoptotic bodies and cell lysis (d). Pre-treatment of IL-1b-stimulated chondrocytes with IGF-1 or/and PDGF-bb for 24 or 48 h
inhibited the degenerative effects of IL-1b (e–j). After 48 h (f, h and j), chondrocytes exhibited as large, viable and flattened cells with numerous tiny
cytoplasmic processes, mitochondria, rough endoplasmic reticulum and other cytoplasmic organelles compared to control chondrocytes. B: a–e:
Redifferentiation of IL-1b-treated chondrocytes in high-density culture by IGF-1 or/and PDGF-bb. Primary chondrocytes were either left
untreated (a) or were treated with 10 ng/ml IL-1b (b), pre-treated with 10 ng/ml IGF-1 (c), 10 ng/ml PDGF-bb (d) or 5 ng/ml PDGF-bb and 5 ng/ml
IGF-1 (e) for 12 h and then stimulated with IL-1b for another 24 h. The cells were transferred to high-density culture for seven days. Ultrastructural
morphology was evaluated by electron microscopy. Control cultures showed characteristic features, including chondrocytes (c) embedded in a well-
developed ECM (m) (a). Treatment with IL-1b for 24 h led to matrix breakdown and cell lysis (b). Pre-treatment with IGF-1 (c), PDGF-bb (d) or both
growth factors in combination (e) resulted in a marked improvement of chondrocyte phenotype and the formation of cartilage nodules. The
formation of a dense ECM (m) surrounding well-developed chondrocytes (c) was observed. 65000; Bars: 1 mm.
doi:10.1371/journal.pone.0028663.g001
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cell surface, formation of apoptotic bodies and degeneration of
ECM structure (Fig. 1B: b). Stimulation of chondrocytes with
PDGF-bb or/and IGF-1 before treatment with IL-1b resulted in
more viable cells exhibiting round or oval shape, euchromatic
nuclei with prominent nucleoli, a well-organized cytoplasm, lipid
droplets and produced a well organized, dense and regular
cartilaginous matrix (Fig. 1B: c–e). Taken together, PDGF-bb and
IGF-1 in combination or alone reduced the degenerative and
cytotoxic effects induced by IL-1b.
Down-regulation of collagen type II, CSPG and b1-
integrin-expression through IL-1b on chondrocytes is
revoked by IGF-1 or/and PDGF-bb in monolayer cultures
Immunoblotting of cartilage ECM components such as collagen
type II, CSPG and the signaling and adhesion molecule b1-
integrin was performed to confirm the results obtained using
ultrastructural techniques (Fig. 2).
Collagen type II, CSPG and b1-integrin expression was down-
regulated in chondrocytes stimulated with IL-1b after 24 (Fig. 2)
and 48 h (data not shown). Chondrocytes treated with PDGF-bb
or/and IGF-1 exhibited augmented collagen type II, CSPG and
b1-integrin expression (Fig. 2) in comparison to IL-1b treated cells.
Pre-treatment with PDGF-bb or/and IGF-1 followed by stimula-
tion with IL-1b resulted in prevention of IL-1b induced effects on
ECM production (Fig. 2). Co-treatment of chondrocytes with a
combination of both growth factors increased the levels of these
proteins compared with each treatment alone. Densitometric
evaluation of a representative western blot experiment was
performed in triplicate.
IGF-1 or/and PDGF-bb suppress IL-1b-induced inhibition
of Shc, Erk 1/2 and SOX-9 in chondrocytes in monolayer
culture
Extracellular signal regulated kinase1/2 (Erk1/2) and Shc
regulate chondrocyte apoptosis, proliferation and also activities of
several nuclear transcription factors, such as SOX-9 [27]. In this
study we found that PDGF-bb or/and IGF-1 up-regulated the
adaptor protein Shc (a more intense 52 kDa band in comparison to
66 and 46 kDa bands) and phosphorylated Erk1/2 (a more intense
42 kDa band in comparison to 44 kDa band) and inhibited down-
regulation in Shc and phosphorylated Erk1/2 expression induced
byIL-1b(Fig.3).Interestingly,a combinationofbothgrowthfactors
exhibited stronger stimulation in Shc expression and Erk1/2
phosphorylation than each growth factor by itself (Fig. 3). The
cartilage master transcription factor SOX-9 regulates cartilaginous
specific matrix production and plays a pivotal role in chondrocyte
differentiation [28]. To investigate whether growth factors are
potent to activate SOX-9 in chondrocytes, primary chondrocytes in
monolayer culture were either left unstimulated or stimulated with
PDGF-bb or/and IGF-1 or were pretreated with PDGF-bb or/and
IGF-1 for 12 h and then stimulated with IL-1b for 24 h (Fig. 3) and
48 h (data not shown), and the cell lysates were analyzed by
immunoblotting. The results demonstrated that PDGF-bb or/and
IGF-1 stimulated SOX-9 expression and inhibited IL-1b-induced
decreases in SOX-9 expression. Quantitative analysis of western
blot results performed in triplicate (Fig. 3) exhibited treatment of
chondrocytes with PDGF-bb or/and IGF-1 stimulated SOX-9
expression in comparison to IL-1b treated chondrocytes (Fig. 3).
Taken together, these results showed that PDGF-bb or/and
IGF-1 augment Shc, Erk1/2 and SOX-9 expression and
counteract IL-1b-induced effects on the above-mentioned mole-
cules in chondrocytes (Fig. 3).
IGF-1 or/and PDGF-bb inhibit IL-1b-induced NF-kB
dependent pro-inflammatory and matrix degradation
and apoptotic gene products in chondrocytes in
monolayer cultures
We investigated whether PDGF-bb or/and IGF-1 can modulate
IL-1b-induced NF-kB-regulated gene products involved in the
inflammation and degradation processes in cartilage tissue. It has
been already implicated that IL-1b stimulation activates COX-2,
MMP-9, MMP-13 and caspase-3 cleavage [13,16].
These experiments were designed to determine whether both
growth factors are able to inhibit expression of proteins activated
by IL-1b. Expression of COX-2, MMP-9, MMP-13 and caspase-3
cleavage was prominent in chondrocytes stimulated with IL-1b
and was blocked in chondrocytes treated with PDGF-bb or/and
IGF-1 (Fig. 4). Expression of above mentioned proteins were not
inhibited completely by each growth factor alone in IL-1b-
stimulated cells, whereas combinational pre-treatment of the
growth factors was effective in inhibition of these pro-inflamma-
tory and matrix degrading enzymes in the same manner in
chondrocytes (Fig. 4).
Cumulative inhibition effect of IGF-1 or/and PDGF-bb on
IL-1b-induced NF-kB activation in chondrocytes in
monolayer cultures
Based on the above data, we speculated that these growth
factors might inhibit the NF-kB pathway. NF-kB is a regulator of
inflammatory cytokines gene expression and plays a critical role in
inflammatory responses. After phosphorylation, ubiquitination
and degradation of Ik-Ba, NF-kB translocates to the nucleus and
binds (thus activating) the promoter of target genes [17]. To
evaluate, whether IGF-1 or/and PDGF-bb inhibit the IL-1b-
induced activation of NF-kB, nuclear protein extracts from serum-
starved chondrocytes were probed for the phosphorylated form of
NF-kB after pre-treatment with IGF-1, PDGF-bb and with IGF-1
and PDGF-bb for the indicated times followed by IL-1b
stimulation for 30 min (Fig. 5). The western blot analysis
confirmed that co-treatment of IGF-1 or PDGF-bb inhibited IL-
1b-induced NF-kB activation in a time-dependent manner.
Moreover, addition of both growth factors showed synergistic
effects and inhibited the IL-1b-induced NF-kB activation. Taken
together, these results indicate that IGF-1 and PDGF-bb act
synergistically in inhibiting the activation of NF-kB more than
each other.
BMS-345541 (specific IKK inhibitor) suppresses IL-1b-
induced inhibition of cartilage specific matrix, Shc, Erk
1/2 and SOX-9 in chondrocytes in monolayer culture
We next focused on the causal relationship between growth
factor receptors and NF-kB signaling pathways. BMS is a potent
and specific IKK inhibitor and can effectively inhibit NF-kB
activation induced by diverse stimuli [29,30]. Therefore, we
treated primary chondrocytes with BMS to determine whether the
effects of IL-1b (as well as their reversal by IGF-1 and PDGF-bb)
on chondrocytes is also associated with an altered activation status
of the IKK-NF-kB pathway and whether it suppressed the
destructive effects of IL-1b in a similar manner to IGF-1/PDGF-
bb. Serum starved chondrocytes were treated with BMS or IL-1b,
or pre-treated with BMS and then co-treated with IL-1b.A s
shown in Figure 6, treatment of chondrocytes with IL-1b alone
inhibited cartilage specific matrix expression (data not shown),
phosphorylated Erk1/2, Shc, SOX-9 expression and stimulated
caspase-3 cleavage (Fig. 6). The basal levels of cartilage specific
matrix expression (data not shown), phosphorylated Erk1/2, Shc,
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28663Figure 2. Effects of IGF-1 or/and PDGF-bb on IL-1b-induced inhibition of cartilage ECM expression in chondrocytes. Western blot
analysis was performed to evaluate the effects of IGF-1 or/and PDGF-bb on IL-1b-induced inhibition of chondrogenic potential in chondrocytes. Whole
cell lysates were probed with antibodies to collagen type II, cartilage specific proteoglycan (CSPG) and b1-integrin. Primary chondrocytes were
treated with 10 ng/ml IL-1b, 10 ng/ml PDGF-bb, 10 ng/ml IGF-1 or 5 ng/ml PDGF-bb and 5 ng/ml IGF-1, or were pre-treated with 10 ng/ml PDGF-bb,
10 ng/ml IGF-1 or 5 ng/ml PDGF-bb and 5 ng/ml IGF-1 for 12 h and then stimulated with IL-1b for 24. Untreated chondrocytes had strong production
of collagen type II, CSPG and b1-integrin, and stimulation with IL-1b alone markedly reduced these proteins. Pre-treatment of the chondrocytes with
IGF-1 or/and PDGF-bb, however inhibited adverse effects of IL-1b. This was confirmed by quantitative densitometry. Expression of the housekeeping
gene b-actin remained un-affected.
doi:10.1371/journal.pone.0028663.g002
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28663Figure 3. Effects of IGF-1 or/and PDGF-bb on IL-1b-induced inhibition of signaling proteins expression in chondrocytes. To evaluate
the effects of IGF-1 and/or PDGF-bb on IL-1b-induced inhibition of MAPK signaling proteins in chondrocytes, whole cell lysates were probed with
antibodies to Shc, Erk1/2 and SOX-9. Primary chondrocytes were either stimulated with 10 ng/ml IL-1b, 10 ng/ml PDGF-bb, 10 ng/ml IGF-1 or
combination of both growth factor (5 ng/ml each) or pre-treated for 12 h with 10 ng/ml PDGF-bb, 10 ng/ml IGF-1 or combination of both (5 ng/ml
each) followed by 10 ng/ml IL-1b for 24. Untreated cultures showed high expression of Shc, Erk1/2, and SOX-9, while IL-1b alone resulted in inhibition
of Erk1/2, Shc as well as SOX-9 production. However, pre-treatment of cultures with IGF-1 or/and PDGF-bb inhibited the adverse effects of IL-1b and
chondrocytes produced large amounts of Shc, Erk1/2 and SOX-9 at levels similar to control cultures. The results were confirmed by quantitative
densitometry.
doi:10.1371/journal.pone.0028663.g003
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28663SOX-9 expression and caspase-3 cleavage were not significantly
changed after incubation with BMS (Fig. 6). Moreover, chondro-
cytes exposed to 5 mM BMS for 12 h followed by stimulation with
IL-1b for 24 h, still exhibited a significant increase in cartilage
specific matrix expression (data not shown), Erk1/2 phosphory-
lation, Shc, SOX-9 expression and exhibited a significant decrease
in caspase-3 cleavage in a similar way to PDGF-bb or/and IGF-1
(Fig. 6). Taken together, these findings demonstrate that the IKK
inhibitor (BMS) suppresses, in a similar way to PDGF-bb or/and
IGF-1, the destructive effects of IL-1b and that IKK (at least in
part) is one the kinases which plays an important role in growth
factor receptor signalling pathways in chondrocytes.
IGF-1 or/and PDGF-bb inhibit IL-1b-dependent IkBa
degradation in chondrocytes in monolayer cultures
PDGF-bb and IGF-1 inhibited IL-1b-induced activation of NF-
kB. Therefore, we examined the upstream mechanisms of NF-kB
activation by IL-1b in chondrocytes. It is well known that the
phosphorylation and degradation of IkBa, the natural blocker of
NF-kB is required for the activation of NF-kB [31]. To test
whether inhibition of IL-1b-induced NF-kB activation occurs
through inhibition of IkBa degradation, we treated cells with
PDGF-bb and IGF-1, followed by IL-1b stimulation and probed
them for NF-kB activation in the nucleus and for IkBa activation
in the cytoplasm by western blot analysis. The activation of NF-kB
increased in the presence of IL-1b, whereas PDGF-bb or IGF-1-
treated cells showed significantly decreased NF-kB activation even
after 60 min of IL-1b stimulation (Fig. 7A–B). Interestingly, co-
treatment of the chondrocytes with combinations of the two
Figure 4. Effects of IGF-1 or/and PDGF-bb on IL-1b-induced NF-kB-dependent pro-inflammatory, pro-apoptotic and matrix
degrading gene products in chondrocytes. To determine whether IGF-1 or/and PDGF-bbexert effects on IL-1b-induced NF-kB-dependent
expression of pro-inflammatory, pro-apoptotic and matrix degrading gene products, primary chondrocytes were either stimulated with 10 ng/ml IL-
1b, 10 ng/ml PDGF-bb, 10 ng/ml IGF-1 or combination of both growth factors (5 ng/ml each) or pre-stimulated for 12 h with 10 ng/ml PDGF-bb,
10 ng/ml IGF-1 or combination of both growth factors (5 ng/ml each) followed by 10 ng/ml IL-1b for 24. Equal amounts of total proteins were
separated by SDS-PAGE and analyzed by immunoblotting using antibodies raised against COX-2, MMP-9 and MMP-13 and active caspase-3.
Stimulation with IL-1b resulted in production of COX-2, MMP-9, MMP-13 and caspase-3 cleavage. Pre-treatment with a combination of both IGF-1 or/
and PDGF-bb downregulated COX-2, MMP-9, MMP-13 and cleaved caspase-3.
doi:10.1371/journal.pone.0028663.g004
Figure 5. Inhibition of IL-1b-induced NF-kB activation and
nuclear translocation by IGF-1 or/and PDGF-bb in primary
chondrocytes. Primary chondrocytes were either stimulated with
10 ng/ml IL-1b, pre-stimulated with 10 ng/ml PDGF-bb, 10 ng/ml IGF-1
or a combination of both growth factors (5 ng/ml each) for the
indicated times and then treated with 10 ng/ml IL-1b for 30 min.
Nuclear extracts were prepared and assayed for NF-kB activation by
western blot analysis. The results shown are representative of three
independent experiments.
doi:10.1371/journal.pone.0028663.g005
Figure 6. IKK inhibitor suppresses IL-1b-induced inhibition of
Shc, Erk 1/2, SOX-9 and stimulation of caspase-3 cleavage in
chondrocytes in monolayer culture. Primary chondrocytes were
either stimulated with 10 ng/ml IL-1b,5mM BMS-345541 (BMS) or were
pre-stimulated for 12 h with 5 mM BMS followed by 10 ng/ml IL-1b for
24. Whole cell lysates were probed with antibodies to Shc, Erk1/2, SOX-
9 and active caspase-3. Untreated cultures showed high expression of
Shc, Erk1/2 SOX-9 and no cleavage of caspase-3, while incubation with
IL-1b alone resulted in suppression of Shc, Erk1/2 as well as SOX-9
production and stimulation of caspase-3 cleavage. However, pre-
treatment of cultures with BMS inhibited the adverse effects of IL-1b
and chondrocytes produced large amounts of Shc, Erk1/2 as well as
SOX-9 proteins and the production of active caspase-3 was inhibited.
doi:10.1371/journal.pone.0028663.g006
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28663growth factors completely suppressed the IL-1b-induced NF-kB
activation (Fig. 7C). IL-1b induced IkBa degradation in control
cells within 5 min but not at all in PDGF-bb or/and IGF-1-treated
cells (Fig. 7A–C). These results indicated that PDGF-bb and IGF-
1 inhibit both IL-1b-induce NF-kB activation and IkBa
degradation. Data shown are representative of three independent
experiments.
IGF-1 or/and PDGF-bb block IL-1b-dependent IkBa
Phosphorylation in chondrocytes in monolayer cultures
To examine whether the inhibition of IL-1b-induced IkBa
degradation is through inhibition of IkBa phosphorylation,
chondrocytes were treated with PDGF-bb or/and IGF-1 and
then with IL-1b and examined for IkBa phosphorylation in the
cytoplasm by western blot analysis. IL-1b-induced IkBa phos-
phorylation was almost completely blocked by PDGF-bb or IGF-1
(Fig. 7A–B). Interestingly, co-treatment of the chondrocytes with
combinations of the two growth factors completely suppressed the
IL-1b-induced IkBa phosphorylation (Fig. 7C).
IGF-1 or/and PDGF-bb block IL-1b-induced
phosphorylation and nuclear translocation of NF-kB
(p65) in chondrocytes in monolayer cultures
Western blot analysis showed that IL-1b induced the phos-
phorylation of the cytoplasmic pool of p65 in a time-dependent
manner, and p65 phosphorylation could be seen as early as 5 min
(Fig. 8). Pre-treatment with PDGF-bb or/and IGF-1 inhibited the
IL-1b-induced phosphorylation of cytoplasmic p65. IL-1b also
induced p65 phosphorylation in the nuclear fraction in a time
dependent manner, and PDGF-bb and IGF-1 blocked IL-1b-
induced translocation of p65 to the nucleus (Fig. 8A–B).
Interestingly, co-treatment of the chondrocytes with a combina-
tion of the two growth factors decreased the levels of these proteins
more than each agent by itself (Fig. 8C).
Figure 7. A–C: Effects of IGF-1 or/and PDGF-bb on IL-1b-
induced IkB-a phosphorylation and degradation and p65
phosphorylation in chondrocytes in monolayer cultures.
Primary chondrocytes were either stimulated with 10 ng/ml IL-1b,
pre-stimulated with 10 ng/ml PDGF-bb, 10 ng/ml IGF-1 or a combina-
tion of both growth factors (5 ng/ml each) for 12 h and treated with
10 ng/ml IL-1b for the indicated times. Cytoplasmic extracts were
prepared, fractionated (500 ng protein per lane) on 10% SDS–PAGE,
and electrotransferred onto nitrocellulose membranes. Western blot
analysis was performed with anti-phospho-specific-IkB-a, anti-IkB-a,
anti-phospho-specific p65, anti-p65 antibodies and anti-b-actin (con-
trol). The results shown are representative of three independent
experiments.
doi:10.1371/journal.pone.0028663.g007
Figure 8. A–C: Effects of IGF-1 or/and PDGF-bb on IL-1b-
induced p65 phosphorylation and nuclear translocation in
chondrocytes in monolayer cultures. Primary chondrocytes were
either stimulated with 10 ng/ml IL-1b, pre-stimulated with 10 ng/ml
PDGF-bb, 10 ng/ml IGF-1 or combination of both growth factors (5 ng/
ml each) for 12 h and treated with 10 ng/ml IL-1b for the indicated
times. Nuclear extracts were prepared, fractionated (500 ng protein per
lane) on 10% SDS–PAGE and electrotransferred onto nitrocellulose
membranes. Western blot analysis was performed with anti-phospho-
specific-p65, anti-p65 antibodies and anti-PARP (control). The results
shown are representative of three independent experiments.
doi:10.1371/journal.pone.0028663.g008
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28663Effect of IGF-1 or/and PDGF-bb on IL-1b-induced
acetylation of NF-kB in chondrocytes in monolayer
cultures
Acetylation of p65 plays an essential role in IkBa-mediated
activation of NF-kB transcriptional activity [32], therefore we
investigated the effect of PDGF-bb or/and IGF-1 on the induction
of p65 acetylation by IL-1b. The chondrocytes were pre-treated
with PDGF-bb or/and IGF-1 for 4 h and then exposed to IL-1b
for the indicated times. Whole-cell extracts were examined and
immunoprecipitated with anti-p65 antibody, and western blot
analysis was performed using anti-acetyl lysine antibody. As shown
in Fig. 9, IL-1b induced acetylation of p65 in a time dependent
manner. In contrast to this, pre-treatment of chondrocytes with
the PDGF-bb or/and IGF-1 followed by stimulation with IL-1b
resulted in an inhibition of cytokine-induced effects on the
acetylation of p65 (Fig. 9A–C). Interestingly, co-treatment of the
chondrocytes with combinations of the two growth factors
completely suppressed the IL-1b-induced acetylation of p65
(Fig. 9C).
Effect of IGF-1 or/and PDGF-bb on IL-1b-induced
activation of IKK in chondrocytes in monolayer cultures
IKK is required for cytokine-induced phosphorylation of IkBa
[31]. We further evaluated the effect of PDGF-bb or/and IGF-1
on IL-1b-induced IKK activation, which is required for IL-1b-
induced phosphorylation of IkBa. The results from the immune
complex kinase assay showed that IL-1b induced the activation of
IKK in a time dependent manner. In contrast, pre-treatment of
chondrocytes with the PDGF-bb or IGF-1 followed by stimulation
with IL-1b resulted in an inhibition of cytokine-induced effects on
the activation of IKK (Fig. 10A–B). Co-treatment of the
chondrocytes with combinations of the two growth factors
completely suppressed IL-1b-induced activation of IKK more
than each agent by itself (Fig. 10C). To determine whether BMS-
345541, the specific inhibitor of IKK [29] can inhibit the NF-kB
pathway like PDGF-bb or/and IGF-1, we analysed the effect of
BMS on IL-1b-induced IKK activation, which is required for IL-
1b-induced phosphorylation of IkBa. Immune complex kinase
assays showed that IL-1b induced the activation of IKK in a time
dependent manner. In contrast, pre-treatment of chondrocytes
with BMS followed by stimulation with IL-1b resulted in an
inhibition of cytokine-induced effects on the activation of IKK
(Fig. 10D). IL-1b, BMS, PDGF-bb or/and IGF-1 had no direct effect
on the expression of IKK-a or IKK-b proteins (Fig. 10).
Effect of IGF-1 or/and PDGF-bb on IL-1b-induced
activation of Akt in chondrocytes in monolayer cultures
Activation of NF-kB requires up-stream kinases including Akt
[33], therefore we examined the effect of growth factors on Akt
activation. Cells were treated with PDGF-bb or/and IGF-1 and
then with IL-1b, and cell extracts were prepared followed by
western blot analysis using anti-Akt or anti-phospho specific-Akt
antibodies. The results clearly show that IL-1b induced Akt
activation in a time-dependent manner; PDGF-bb or IGF-1
inhibited this process (Fig. 11A – B ) .C o - t r e a t m e n to ft h e
chondrocytes with combinations of the two growth factors
decreased the levels of this protein more than each agent by
itself (Fig. 11 C). Further, we wanted to know whether these
growth factors impair the association of Akt-protein with IKK-
protein. Therefore, extracts were prepared from IL-1b-treated
cells followed by immunoprecipitation with anti-IKK-a anti-
body and western blot analysis using anti-Akt antibody. IL-1b
induced association between IKK and Akt in a time-dependent
manner and PDGF-bb or/and IGF-1 suppressed that (Fig. 11
A–B). Co-treatment of the chondrocytes with combinations of
the two growth factors decreased the levels of this association
b e t w e e nA k ta n dI K Kp r o t e i nm o r et h a ne a c ha g e n tb yi t s e l f
(Fig. 11 C).
Figure 9. A–C: Effects of IGF-1 or/and PDGF-bb on the IL-1b-induced p65 acetylation in chondrocytes in monolayer cultures. Primary
chondrocytes were either stimulated with 10 ng/ml IL-1b, pre-stimulated with 10 ng/ml IGF-1, 10 ng/ml PDGF-bb or a combination of both growth
factors (5 ng/ml each) for 12 h and treated with 10 ng/ml IL-1b for the indicated times. Whole-cell extracts were prepared and immunoprecipitated
with an anti-p65 antibody. Western blot analysis was then performed with an anti-acetyl-lysine antibody or with an anti-p65 antibody. The results
shown are representative of three independent experiments.
doi:10.1371/journal.pone.0028663.g009
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on IL-1b-induced c-Src phosphorylation in chondrocytes
To examine whether c-Src phosphorylation was necessary for
the IL-1b-induced NF-kB induction, activation of this kinase was
determined by western blotting with an antibody specific for the
phosphorylated c-Src. As shown in Fig. 12A, IL-1b stimulated
phosphorylation of c-Src in chondrocytes and reached a maximum
within 5 to 10 min. This IL-1b-stimulated c-Src phosphorylation
was inhibited by pre-treatment with inhibitors of c-Src (PP1), but
not by IGF or/and PDGF-bb (Fig. 12B-D). These results indicate
that IL-1b-stimulated c-Src phosphorylation was not mediated
through IGF or/and PDGF. Further, these results suggest a link
between activation of c-Src and induction of NF-kB activation by
IL-1b in chondrocytes.
Effect of Src-, PI-3K-, AKT-inhibitors and IGF-1 or/and
PDGF-bb on IL-1b-induced phosphorylation of NF-kBi n
chondrocytes
To investigate the role of the c-Src/PI-3K/Akt signaling
pathway in regulating of IL-1b-mediated NF-kB activation, the
level of NF-kB protein was analyzed using selective kinase
inhibitors. Chondrocytes were pre-treated with inhibitors of c-
Src (PP1), PI-3K (wortmannin) and Akt (SH-5), respectively for
1 h, and then co-treated with 10 ng/ml IL-1b for 1 h (Fig. 13A).
In parallel with the inhibition of NF-kB activation, chondrocytes
were pre-treated with IGF-1 (10 ng/ml) or PDGF-bb (10 ng/ml)
or a combination of both growth factors (each 5 ng/ml) for 4 h,
and then exposed to 10 ng/ml IL-1b for 1 h (Fig. 13B). As shown
in Fig. 13A–B, the activation of NF-kB in chondrocytes was
significantly increased by incubation with IL-1b. However, the
specific inhibitors for c-Src, PI-3K and Akt blocked IL-1b-
stimulated NF-kB. In addition, IL-1b-stimulated NF-kB activation
was also significantly inhibited by pre-incubation with IGF-1 or/
and PDGF-bb. These results further suggest that IGF-1 or/and
PDGF-bb play an important role in down-regulation of the IL-1b-
induced NF-kB activation in chondrocytes, at least in part through
inhibition of the c-Src/PI3K/Akt signaling pathway.
Discussion
In this study we examined whether the anti-inflammatory and
anti-apoptotic effects of IGF-1 or/and PDGF-bb in primary
chondrocytes are mediated through similar signalling mechanisms
and whether combining these two growth factors exerts synergistic
effects on IL-1b-mediated cellular responses, NF-kB mediated
signal transduction pathways and the regulation of NF-kB
regulated gene expression. Our results demonstrated for the first
time evidence that in chondrocytes, IKK-inhibitor (BMS), IGF-1
or/and PDGF-bb can suppress IL-1b-induced NF-kB activation
and apoptosis, and this may be mediated through c-Src dependent
suppression of PI-3K/Akt, revealed by using pharmacological
inhibitors PP1, wortmannin and SH-5, respectively.
In several previous studies, we have demonstrated that IL-1b
induces down regulation of chondrocyte ECM molecules and
apoptosis through activation of NF-kB dependent pathways and
growth factors can block these effects [14,25,34,35]. Therefore, in
this study, we examined whether alternative signaling molecule(s)
to downstream pathway of IL-1b, such as c-Src/PI-3K/Akt
activation pathway, are involved in IL-1b-induced NF-kB
activation and cell apoptosis in chondrocytes. Using monolayer
cultured chondrocytes we found that IGF-1 or/and PDGF-bb or
BMS inhibit IL-1b-induced NF-kB activation through the
suppression of IkBa phosphorylation, IkBa degradation, IkBa
kinase activity and NF-kB–dependent gene products involved in
inflammation (COX-2, MMPs) and activation of caspase-3.
Moreover, inhibition of NF-kB activation by IGF-1 or/and
PDGF-bb or BMS was correlated with suppression of p65
phosphorylation, p65 nuclear translocation and p65 acetylation.
Previous work from our group has shown that growth factors
(IGF-1 or/and TGF-b1) exert additive anabolic and anti-inflam-
matory effects on IL-1b signalling pathways in chondrocytes in vitro
[12,26]. In the present study, we demonstrated that growth factors
(IGF-1 or/and PDGF-bb) exert their anabolic and anti-inflamma-
tory effects on the maintenance of the chondrogenic potential in
chondrocytes in vitro by inhibiting of NF-kB pathway. Moreover,
several investigators have reported that many pro-inflammatory
effects of IL-1b and TNF-a are regulated by stimulation of the
ubiquitous transcription factor NF-kB [36,37,38], which plays a
crucial role in OA, leading to cartilage destruction and articular
Figure 10. A–D: Effects of IGF-1 or/and PDGF-bb or IKK-
inhibitor (BMS) on the IL-1b-induced IKK activation in chon-
drocytes in monolayer cultures. Primary chondrocytes were either
stimulated with 10 ng/ml IL-1b, pre-stimulated with 10 ng/ml IGF-1,
10 ng/ml PDGF-bb, a combination of both growth factors (5 ng/ml
each) or 5 mM BMS-345541 (BMS) for 12 h and treated with 10 ng/ml IL-
1b for the indicated times. Whole-cell extracts were immunoprecipitat-
ed with an antibody against IkB kinase (IKK)and then analyzed by an
immune complex kinase assay as described in Materials and Methods.
To examine the effect of IGF-1 or/and PDGF-bb or BMS on the level of
activation of IKK proteins, whole-cell extracts were fractionated (500 ng
protein per lane) on SDS–PAGE and examined by western blot analysis
using anti-IKK-a and anti-IKK-b antibodies. The results shown are
representative of three independent experiments.
doi:10.1371/journal.pone.0028663.g010
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BMS modulates the activation of NF-kB-regulated gene products
(i.e. COX-2, MMP-9 and MMP-13, caspase-3 cleavage), which
partly explains the anti-apoptotic and anti-inflammatory effects of
IGF-1 or/and PDGF-bb in chondrocytes.
In this study we show that IL-1b-induces down-regulation of
collagen type II, cartilage-specific proteoglycans, b1-integrin and
the expression of MAPKinase specific proteins. This process is
accompanied by inhibition of the SOX-9 protein expression in
chondrocytes, in agreement with previous studies of articular
chondrocytes from our and other laboratories [12,34,40].
Moreover, SOX-9 is required for expression of cartilage-specific
ECM molecules in cartilage [41,42]. Interestingly, in the present
study, the down-regulation of the mentioned proteins was
inhibited by pre-treating the cells with a specific IKK-inhibitor
(BMS) or IGF-1 or/and PDGF-bb followed by stimulation with
IL-1b. Further, co-treatment of the chondrocytes with combina-
tions of the both growth factors increased the levels of these
proteins more than each agent by itself. Moreover, as it has been
previously demonstrated by our group, activation of b1-integrin
and adaptor protein Shc are key events for stimulation of
MAPKinase intracellular signaling pathway [20,43], which up
regulates SOX-9 expression in chondrocytes in vitro [12]. In
agreement with previous reports from other laboratories, we have
revealed that pro-inflammatory cytokines could reduce transcrip-
tion factor SOX-9 expression by a IKK-NF-kB-dependent
pathway, post-transcriptional mechanism in chondrocytes
[44,45], suggesting a collaboration between growth factors in a
common/shared biochemical signaling pathway.
Activation of growth factor receptor results in regulation of
gene expression involved in cell proliferation, survival, migration
or anti-inflammatory responses [46]. We found that IGF-1 and
PDGF-bb suppressed the IL-1b-induced NF-kB activation. How
IGF-1 and PDGF-bb suppress IL-1b-induced NF-kB activation
in chondrocytes is not fully understood. In response to IL-1b,N F -
kB activation proceeds sequentially through activation of IKK,
phosphorylation and ubiquitination of IkB-a, and finally
degradation of IkB-a and the release of NF-kB [31]. How
IGF-1 or/and PDGF-bb inhibits IKK activation was also
investigated. The multiple signaling steps that lead to NF-kB
activation are not fully understood. Further, protein kinase B
(Akt) has been reported to activate IKK [33]. Our results show
that IGF-1 or/and PDGF-bb suppressed IL-1b-induced Akt
activation as well as Akt-IKK association. These results indicate
that IGF-1 and PDGF-bb may inhibit IKK activation through
suppression of Akt activation. Moreover, it has been shown that
IL-1b activates the up-stream kinase c-Src which in turn
stimulates the downstream PI-3K/Akt signaling pathway [47].
Thus, we examined whether PI-3K plays a role in IL-1b-induced
NF-kB activation and whether wortmannin inhibits PI-3K
pathway in chondrocytes, since it was not reported before. Our
results show that wortmannin like IGF-1 and PDGF-bb inhibited
NF-kB activation in chondrocytes. In fact, it has been shown that
NF-kB activation requires a PI-3K/Akt signaling pathway
[33,48,49]. The results obtained in this study with IL-1 b-
induced NF-kB activation are consistent with these reports. Our
results also indicate that the activation of NF-kBb yI L - 1 b is
blocked by SH-5 and PP1, specific inhibitors of protein kinase B
Figure 11. A–C: Effects of IGF-1 or/and PDGF-bb on the IL-1b-induced Akt activation in chondrocytes in monolayer cultures. Primary
chondrocytes were either stimulated with 10 ng/ml IL-1b, pre-stimulated with 10 ng/ml IGF-1, 10 ng/ml PDGF-bb or a combination of both growth
factors (5 ng/ml each) for 12 h and treated with 10 ng/ml IL-1b for the indicated times. Whole cell extracts were immunoprecipitated with anti-IKK-a
antibody followed by western blot analysis using anti-Akt, anti-phospho-specific Akt and anti-IKK-a antibodies. The results shown are representative
of three independent experiments.
doi:10.1371/journal.pone.0028663.g011
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could play a synergistic functional cooperation with PI-3K
[33,47].
We found further that IL-1b induces NF-kB activation in a
concentration-dependent manner and c-Src was required for the
NF-kB activity induced by IL-1b. This activation was inhibited by a
specific c-Src inhibitor (PP1) but not by IGF-1 or/and PDGF-bb.
Further, the data showed that activation of c-Src by IL-1b was
linked to the PI-3K/Akt cascade leading to NF-kB induction and
activity in chondrocytes. These results suggest that in chondrocytes,
IL-1b-induced NF-kB activation and activity is mediated, at least in
part through a c-Src/PI-3k/Akt component and this signaling
pathway was inhibited by receptor tyrosine kinases, including the
insulin-likegrowth factor-1receptor andtheplatelet-derived growth
factor. These findings further confirmed that IL-1b-induced NF-kB
activation was mediated through either PI-3K/Akt-dependent
pathway or c-Src-dependent activation of the PI-3K/Akt pathways.
The precise nature of the connection between IL-1b signaling
and downstream kinases is not well established in chondrocytes. It
is known that PI-3K/Akt signaling pathway is involved in IL-1b-
mediated signalling events and this pathway is activated
originating from cell surface receptors, such as PDGFR and other
growth factors receptors in various cell types [50]. In fact, several
reports have shown that Akt and PI-3K/Akt phosphorylation is
required for pro-inflammatory cytokine-induced NF-kB activation
in various cell types [33,47,49]. Our results were consistent with
these studies demonstrating that Akt is an important protein in this
cascade for NF-kB activation and translocation from cytosol into
nucleus through targeting IKKs or phosphorylation of p65 [51] in
response to IL-1b and Akt is a downstream target for inhibition
effects of IGF-1 or/and PDGF-bb in chondrocytes. Several lines of
evidence have reported that IL-1b/IL-1bR induced phosphory-
lation of tyrosine residues of c-Src [47,51,52], but little is known
about the mechanisms underlying IL-1b-stimulated NF-kB
activation mediated through c-Src-dependent pathway in chon-
drocytes. Our results also showed that IL-1b-enhanced NF-kB
(p65) phosphorylation and translocation was significantly attenu-
ated by pre-treatment with the inhibitors of Src, PI3K, Akt and the
both growth factors, indicating that activation of growth factor
receptors and Src/PI-3K/Akt pathway play an important role in
modulating IL-1b-mediated NF-kB (p65) activation. Our results
demonstrate here that a specific IKK inhibitor (BMS) suppresses
the destructive effects of IL-1b like IGF-1/PDGF-bb. Moreover, it
has been shown in other cell types, that Akt directly phosphor-
ylates IKKs leading to the activation of NF-kB, independent of
mitogen-activated protein kinase kinase-1 and NF-kB inducing
kinase [33]. IKK is, at least in part, the kinase that growth factor
signalling directly interferes with in the Src/PI3K/Akt pathway.
This pathway thus allows growth factors such as PDGF or/and
IGF-1 to inhibit NF-kB activation.
In addition, these results suggest that growth factors added to or
mixed in a cell pellet or 3-D construct can induce both anabolic
mediators and inhibit possible sources of inflammation, making
these growth factors ideal compounds for use in cells used in
autologous chondrocytes transplantation.
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Figure 12. A–D: Effects of PP1 and IGF-1 or/and PDGF-bb on IL-
1b-induced c-Src phosphorylation in chondrocytes in mono-
layer cultures. Primary chondrocytes were either stimulated with
10 ng/ml IL-1b, pre-stimulated with 10 ng/ml IGF-1, 10 ng/ml PDGF-bb
or a combination of both growth factors (5 ng/ml each) for 12 h, or
with PP1 (10 mM) for 1 h and treated with 10 ng/ml IL-1b for the
indicated times. The cell lysates were subjected to 10% SDS-PAGE
(500 ng protein per lane), transferred to nitrocellulose membranes and
then probed using anti-phospho-Src and anti-b-actin (as an indicator of
protein loading in each lane) antibodies. Identical results were obtained
in three independent experiments.
doi:10.1371/journal.pone.0028663.g012
Figure 13. A–B: Effects of Src-, PI-3K-, AKT-inhibitors and IGF-1
or/and PDGF-bb on IL-1b-stimulated phosphorylation of NF-kB
in chondrocytes. Primary chondrocytes were either stimulated with
10 ng/ml IL-1b, pre-stimulated with PP1 (10 mM), wortmannin (20 nM)
and SH-5 (10 mM) for 1 h (A), or with 10 ng/ml IGF-1, 10 ng/ml PDGF-bb
or a combination of both growth factors (5 ng/ml each) for 12 h (B) and
then incubated with IL-1b for 30 min. Nuclear extracts were subjected
to 10% SDS-PAGE (500 ng protein per lane), transferred to nitrocellu-
lose membranes and then probed using an antiserum reactive with an
anti-phospho-p65 or anti-PARP polyclonal antibody (housekeeping
control). Similar results were obtained in three independent experi-
ments.
doi:10.1371/journal.pone.0028663.g013
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